These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 33436578)

  • 1. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis.
    Gao T; Ptashkin R; Bolton KL; Sirenko M; Fong C; Spitzer B; Menghrajani K; Ossa JEA; Zhou Y; Bernard E; Levine M; Martinez JSM; Zhang Y; Franch-Expósito S; Patel M; Braunstein LZ; Kelly D; Yabe M; Benayed R; Caltabellotta NM; Philip J; Paraiso E; Mantha S; Solit DB; Diaz LA; Berger MF; Klimek V; Levine RL; Zehir A; Devlin SM; Papaemmanuil E
    Nat Commun; 2021 Jan; 12(1):338. PubMed ID: 33436578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinction of lymphoid and myeloid clonal hematopoiesis.
    Niroula A; Sekar A; Murakami MA; Trinder M; Agrawal M; Wong WJ; Bick AG; Uddin MM; Gibson CJ; Griffin GK; Honigberg MC; Zekavat SM; Paruchuri K; Natarajan P; Ebert BL
    Nat Med; 2021 Nov; 27(11):1921-1927. PubMed ID: 34663986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal Hematopoiesis: Origins and determinants of evolution.
    Mendez LM; Patnaik MM
    Leuk Res; 2023 Jun; 129():107076. PubMed ID: 37075557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for clonal hematopoiesis of indeterminate potential and mosaic chromosomal alterations.
    Jakubek YA; Reiner AP; Honigberg MC
    Transl Res; 2023 May; 255():171-180. PubMed ID: 36414227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal hematopoiesis and risk for hematologic malignancy.
    Warren JT; Link DC
    Blood; 2020 Oct; 136(14):1599-1605. PubMed ID: 32736382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of mosaic chromosomal alteration fitness.
    Pershad Y; Mack T; Poisner H; Jakubek YA; Stilp AM; Mitchell BD; Lewis JP; Boerwinkle E; Loos RJF; Chami N; Wang Z; Barnes K; Pankratz N; Fornage M; Redline S; Psaty BM; Bis JC; Shojaie A; Silverman EK; Cho MH; Yun JH; DeMeo D; Levy D; Johnson AD; Mathias RA; Taub MA; Arnett D; North KE; Raffield LM; Carson AP; Doyle MF; Rich SS; Rotter JI; Guo X; Cox NJ; Roden DM; Franceschini N; Desai P; Reiner AP; Auer PL; Scheet PA; Jaiswal S; Weinstock JS; Bick AG
    Nat Commun; 2024 May; 15(1):3800. PubMed ID: 38714703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal hematopoiesis and its emerging effects on cellular therapies.
    von Bonin M; Jambor HK; Teipel R; Stölzel F; Thiede C; Damm F; Kroschinsky F; Schetelig J; Chavakis T; Bornhäuser M
    Leukemia; 2021 Oct; 35(10):2752-2758. PubMed ID: 34215849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment.
    von Beck K; von Beck T; Ferrell PB; Bick AG; Kishtagari A
    Blood Cancer J; 2023 Jan; 13(1):5. PubMed ID: 36599826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic and polygenic inheritance become instruments for clonal selection.
    Loh PR; Genovese G; McCarroll SA
    Nature; 2020 Aug; 584(7819):136-141. PubMed ID: 32581363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
    Kishtagari A; Khan MAW; Li Y; Vlasschaert C; Marneni N; Silver AJ; von Beck K; Spaulding T; Stockton S; Snider C; Sochacki A; Dorand D; Mack TM; Ferrell PB; Xu Y; Bejan CA; Savona MR; Bick AG
    Blood Cancer J; 2024 Jan; 14(1):6. PubMed ID: 38225345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clonal hematopoiesis: a risk factor for leukemia and cardiovascular disease?].
    van Zeventer IA; Buisman SC; de Graaf AO; de Haan G; Jansen JH; Huls G
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.
    Hong W; Li A; Liu Y; Xiao X; Christiani DC; Hung RJ; McKay J; Field J; Amos CI; Cheng C
    Cancer Res; 2022 Jan; 82(2):199-209. PubMed ID: 34815255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal hematopoiesis: Molecular and clinical implications.
    Kusne Y; Xie Z; Patnaik MM
    Leuk Res; 2022 Feb; 113():106787. PubMed ID: 35091334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of smoking and risk of clonal hematopoiesis.
    Levin MG; Nakao T; Zekavat SM; Koyama S; Bick AG; Niroula A; Ebert B; Damrauer SM; Natarajan P
    Sci Rep; 2022 May; 12(1):7248. PubMed ID: 35508625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer therapy shapes the fitness landscape of clonal hematopoiesis.
    Bolton KL; Ptashkin RN; Gao T; Braunstein L; Devlin SM; Kelly D; Patel M; Berthon A; Syed A; Yabe M; Coombs CC; Caltabellotta NM; Walsh M; Offit K; Stadler Z; Mandelker D; Schulman J; Patel A; Philip J; Bernard E; Gundem G; Ossa JEA; Levine M; Martinez JSM; Farnoud N; Glodzik D; Li S; Robson ME; Lee C; Pharoah PDP; Stopsack KH; Spitzer B; Mantha S; Fagin J; Boucai L; Gibson CJ; Ebert BL; Young AL; Druley T; Takahashi K; Gillis N; Ball M; Padron E; Hyman DM; Baselga J; Norton L; Gardos S; Klimek VM; Scher H; Bajorin D; Paraiso E; Benayed R; Arcila ME; Ladanyi M; Solit DB; Berger MF; Tallman M; Garcia-Closas M; Chatterjee N; Diaz LA; Levine RL; Morton LM; Zehir A; Papaemmanuil E
    Nat Genet; 2020 Nov; 52(11):1219-1226. PubMed ID: 33106634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causes and consequences of clonal hematopoiesis.
    Weeks LD; Ebert BL
    Blood; 2023 Dec; 142(26):2235-2246. PubMed ID: 37931207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining clonal hematopoiesis of indeterminate potential: evolutionary dynamics and detection under aging and inflammation.
    Goldman EA; Spellman PT; Agarwal A
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 36889927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
    Gibson CJ; Kim HT; Zhao L; Murdock HM; Hambley B; Ogata A; Madero-Marroquin R; Wang S; Green L; Fleharty M; Dougan T; Cheng CA; Blumenstiel B; Cibulskis C; Tsuji J; Duran M; Gocke CD; Antin JH; Nikiforow S; DeZern AE; Chen YB; Ho VT; Jones RJ; Lennon NJ; Walt DR; Ritz J; Soiffer RJ; Gondek LP; Lindsley RC
    J Clin Oncol; 2022 Jan; 40(2):189-201. PubMed ID: 34793200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
    Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
    JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.